These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20188085)

  • 1. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C.
    Ikeda H; Ohkawa R; Watanabe N; Nakamura K; Kume Y; Nakagawa H; Yoshida H; Okubo S; Yokota H; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Koike K; Yatomi Y
    Clin Chim Acta; 2010 May; 411(9-10):765-70. PubMed ID: 20188085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.
    Knapp M; Baranowski M; Czarnowski D; Lisowska A; Zabielski P; Górski J; Musiał W
    Med Sci Monit; 2009 Sep; 15(9):CR490-3. PubMed ID: 19721401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters.
    Ohkawa R; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Tozuka M; Osima N; Yokota H; Ikeda H; Yatomi Y
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):356-63. PubMed ID: 18583619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis.
    Kułakowska A; Zendzian-Piotrowska M; Baranowski M; Konończuk T; Drozdowski W; Górski J; Bucki R
    Neurosci Lett; 2010 Jun; 477(3):149-52. PubMed ID: 20434523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis.
    Sugiura T; Dohi Y; Yamashita S; Ohte N; Ito S; Iwaki S; Hirowatari Y; Ohkawa R; Mishima Y; Yatomi Y; Kimura G; Fujii S
    Coron Artery Dis; 2012 Jun; 23(4):234-8. PubMed ID: 22356865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    Becker S; Kinny-Köster B; Bartels M; Scholz M; Seehofer D; Berg T; Engelmann C; Thiery J; Ceglarek U; Kaiser T
    PLoS One; 2017; 12(3):e0174424. PubMed ID: 28334008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation in patients with chronic hepatitis C.
    Fusegawa H; Shiraishi K; Ogasawara F; Shimizu M; Haruki Y; Miyachi H; Matsuzaki S; Ando Y
    Tokai J Exp Clin Med; 2002 Dec; 27(4):101-6. PubMed ID: 12713014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of two photoactivatable analogues of the growth-factor-like mediator sphingosine 1-phosphate: differential interaction with protein targets.
    Lu X; Cseh S; Byun HS; Tigyi G; Bittman R
    J Org Chem; 2003 Sep; 68(18):7046-50. PubMed ID: 12946147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
    Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5.
    Ikeda H; Satoh H; Yanase M; Inoue Y; Tomiya T; Arai M; Tejima K; Nagashima K; Maekawa H; Yahagi N; Yatomi Y; Sakurada S; Takuwa Y; Ogata I; Kimura S; Fujiwara K
    Gastroenterology; 2003 Feb; 124(2):459-69. PubMed ID: 12557151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate.
    Bode C; Sensken SC; Peest U; Beutel G; Thol F; Levkau B; Li Z; Bittman R; Huang T; Tölle M; van der Giet M; Gräler MH
    J Cell Biochem; 2010 Apr; 109(6):1232-43. PubMed ID: 20186882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
    Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
    Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate accelerates wound healing in diabetic mice.
    Kawanabe T; Kawakami T; Yatomi Y; Shimada S; Soma Y
    J Dermatol Sci; 2007 Oct; 48(1):53-60. PubMed ID: 17643267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
    Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of sphingosine-1-phosphate by HPLC after napthalene-2,3-dicarboxaldehyde (NDA) derivatization.
    He X; Huang CL; Schuchman EH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):983-90. PubMed ID: 19285924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.